The purchase order is for the sale of US $37,500 of enzyme to be delivered immediately. The name of the company purchasing the enzyme is not disclosed for competitive reasons. This sale of carbonic anhydrase enzyme (CA) to this leading provider of innovative technology is a trial to quantify the benefits of using CA to enhance the production of algae.
A positive result of this CA trial and the commercialization of this algae-based technology could lead to further sales of CA. Algae cultivation and processing is considered as an environmentally attractive method to produce biofuel and other value-added bio-products.
“While CO2 capture and reuse is our current focus, there are other market applications for robust and low-cost carbonic anhydrase enzyme, such as its use for algae production, which are covered by our intellectual property,” stated Evan Price, President and CEO of CO2 Solutions Inc. “We are well positioned to serve these markets and look forward to working with this company and others in the high potential algae and biofuel production segment.”